Article

AMCP Nexus 2022 Draws 2500 Managed Care Professionals

The Academy of Managed Care Pharmacy kicks off AMCP Nexus 2022 with a wide variety of educational sessions and policy discussions.

The Academy of Managed Care Pharmacy has kicked off AMCP Nexus 2022 with a wide variety of educational sessions and policy discussions covering such hot topics as prescription digital therapeutics and HIV pre-exposure prophylaxis, and Pharmacy Times® will provide coverage of the meeting.

The conference, held October 11-14 at the Gaylord National Convention Center in National Harbor, Maryland, is expected to attract approximately 2500 pharmacists, health care executives, and other professionals involved in managing the pharmacy benefits of nearly 300 million Americans.

The programming features more than 26 educational sessions including continuing education opportunities, 3 keynote presentations, 15 satellite symposia, an exhibition hall, and networking events.

The meeting kicks off with a keynote address by Leana Wen, MD, MSc, former commissioner of the Baltimore City Health Department in Maryland. She is the author of 2 books: Lifelines: A Doctor's Journey in the Fight for Public Health, and When Doctors Don't Listen: How to Avoid Misdiagnoses and Unnecessary Tests.

With a nod to the conference’s location near Washington, D.C., 1 session will focus on state and federal policy updates, including one on the midterm election outlook and its health care implications.

Additional sessions will look at the impact of managed care pharmacists on transgender care and oncology biosimilars.

Related Videos
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Cavan - stock.adobe.com
Image Credit: © utah51 - stock.adobe.com
Image Credit: © Rawpixel.com - stock.adobe.com